ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0218

Creating an EHR Lupus Outreach Workbench to Address Care Gaps

Ross Gilbert1, Starla Blanks2, Joy Buie3, Mary Cronin4, Jake Decker5, Laura Dickmann6, Cristina Drenkard7, Sancia Ferguson8, Shivani Garg9, David Gazeley5, Andrea Gilmore-Bykovskyi10, Gale Johnson11, Patti Katz12, Tristan Lazewski13, S. Sam Lim14, Jenna McGoldrick15, Katrina Phelps10, Edmond Ramly16, Rosalind Ramsey-Goldman17, Ann Rosenthal18, Dawn Thomas-Semanko19, Sarah Stoltz13, Patricia Tellez-giron20, Amannda Weber21, Andrea Wipperfurth13 and Christie Bartels10, 1Johns Hopkins University, Baltimore, MD, 2American College of Rheumatology, Atlanta, GA, 3Lupus Foundation of America, Washington, DC, 4retired, Fox Point, WI, 5Medical College of Wisconsin, Milwaukee, WI, 6Froedtert Health, Waukesha, WI, 7Rollins School of Public Health, Emory University, Atlanta, Georgia, USA, Acworth, GA, 8University of Wisconsin School of Medicine and Public Health, Madison, Madison, WI, 9University of Madison, School of Medicine and Public Health, Madison, WI, 10University of Wisconsin School of Medicine and Public Health, Madison, WI, 11Wisconsin Department of Health Services, Madison, WI, 12UCSF, San Rafael, CA, 13UW Health, Madison, WI, 14Emory University School of Medicine, Atlanta, GA, 15SSM Health, Madison, WI, 16Indiana University - Bloomington, Bloomington, IN, 17Northwestern University Feinberg School of Medicine, Chicago, IL, 18Department of Medicine, Division of Rheumatology, Medical College of Wisconsin, Wisconsin, 19WI Chapter - LFA, Milwaukee, WI, 20University of Wisconsin, School of Medicine and Public Health, Madison, Madison, WI, 21University of Wisconsin (UW), UW Health, Madison, WI

Meeting: ACR Convergence 2025

Keywords: Health Care, Quality Indicators, quality of care, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0210–0232) Measures & Measurement of Healthcare Quality Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Lupus affects up to 1.5 million people in the US with significant health disparities in care and outcomes that call for care delivery innovation. Similar disparities in HIV were addressed using a globally-endorsed Care Continuum model with steps including measuring linkage and retention in specialty care by visits and labs. The Continuum led to evidence-based interventions that improved disease control including an effective Electronic Health Record (EHR) outreach intervention. Given prior success, we aimed to adapt a care retention intervention for SLE. Our objectives were to convene patients, clinicians, public health leaders, and community partners to adapt and design a pilot intervention to address SLE Care Continuum gaps.

Methods: We convened 8 focus groups (3 patient, 3 healthcare, and 2 external rheumatology/public health advisory group meetings) to discuss interventions for care retention in lupus. Participants included 10 patients with SLE, 7 rheumatologists, 2 RNs, 2 primary care physicians, 2 patient advocates, and 3 public health experts. Groups spanned 4 US states, 5 academic centers, 2 countries. Focus groups were a series of 60–90-minute virtual meetings. Transcripts were analyzed using NVivo software for content analysis.Based on suggestions, experts at one academic center co-designed an EHR (Epic) workbench to highlight clinic patients with SLE lacking: (a) rheum clinic visit scheduled or completed in > 6 months or (b) recent laboratory tests (CBC, creatinine, urinalysis protein, complement, dsDNA every 6 months for SLE, 3 months for lupus nephritis. We added hydroxychloroquine (HCQ) and steroid indicators per 2023 ACR SLE clinical quality measures. Inclusion required age ≥18 and at least 1 rheumatologist lupus code; patients without any rheumatology clinic visits (e.g., receiving outside care) were excluded.

Results: Advisors shared desires for patient reminders and outreach for due visits, labs and refills and consistent clinical personnel to address potential barriers (i.e., “patient navigator”). While many supported dedicated patient navigators, clinicians noted low resources and staff turnover as limitations. Based on this input, we designed an EHR staff outreach intervention with potential to scale to other clinics and staff. Three workbench views (Fig 1a-c) included those lacking: 1) visits, 2) lupus labs, or 3) lacking labs with upcoming visits within 2 weeks (to aid pre-visit planning). The workbench also displays all three 2023 ACR lupus clinical quality measures: hydroxychloroquine use, kidney lab testing, and prednisone reduction. Outreach tools consisted of modifying an existing chronic disease outreach letter to indicate a need to call for a visit or labs (Fig 2). Letters could be sent via EHR portal or mail by patient preference; subsequent contacts included calls by RN/MA outreach staff workflow (Fig 3).

Conclusion: Advisors guided adapting a proven EHR outreach intervention for care retention in SLE. Using an EHR workbench and a staff workflow with a simple chronic disease outreach letter, we created tools to address SLE care retention. The workbench also displays all three 2023 ACR lupus quality measures for use in future studies.

Supporting image 1Figure 1: Three Workbench views include 34 columns with selected features shown in A-C. (A) Search panel to specify visit or lab list, (B) Overdue visit and lab list (yellow) with next and last visit dates plus ER and hospital dates, and (C) Other indicators for nephritis, open orders (purple circle), kidney test, HCQ, and steroid indicators (blue box), and adverse Area Deprivation Index (ADI) neighborhood (red) plus preferred language for instance.

Supporting image 2Figure 2: Chronic Disease Outreach Letter staff view (top) and patient view (bottom).

Supporting image 3Figure 3: Process flow diagram for using the Lupus Outreach Workbench


Disclosures: R. Gilbert: None; S. Blanks: None; J. Buie: Bristol-Myers Squibb(BMS), 1, Fate Therapeutics, 1, Genentech, 1, Novartis, 1; M. Cronin: None; J. Decker: None; L. Dickmann: None; C. Drenkard: None; S. Ferguson: None; S. Garg: None; D. Gazeley: None; A. Gilmore-Bykovskyi: None; G. Johnson: None; P. Katz: None; T. Lazewski: None; S. Lim: Accordant, 2, AstraZeneca, 2, Biogen, 5, BMS, 5, Genentech, 2, Gilead, 5, GSK, 2, Novartis, 5, UCB, 5; J. McGoldrick: None; K. Phelps: None; E. Ramly: None; R. Ramsey-Goldman: Ampel Solutions, 2, AstraZeneca, 6, Biogen, 2, Cabaletta, 2, Duke, 2, Exagen Diagnostics, 2, Merck, 2, SUNY Syracuse, 2; A. Rosenthal: None; D. Thomas-Semanko: None; S. Stoltz: None; P. Tellez-giron: None; A. Weber: None; A. Wipperfurth: None; C. Bartels: None.

To cite this abstract in AMA style:

Gilbert R, Blanks S, Buie J, Cronin M, Decker J, Dickmann L, Drenkard C, Ferguson S, Garg S, Gazeley D, Gilmore-Bykovskyi A, Johnson G, Katz P, Lazewski T, Lim S, McGoldrick J, Phelps K, Ramly E, Ramsey-Goldman R, Rosenthal A, Thomas-Semanko D, Stoltz S, Tellez-giron P, Weber A, Wipperfurth A, Bartels C. Creating an EHR Lupus Outreach Workbench to Address Care Gaps [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/creating-an-ehr-lupus-outreach-workbench-to-address-care-gaps/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/creating-an-ehr-lupus-outreach-workbench-to-address-care-gaps/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology